Medical complications after subarachnoid hemorrhage: New strategies for prevention and management

Current Opinion in Critical Care

Volumn 12, Issue 2, 2006, Pages 78-84

  Wartenberg, Katja E ^a   Mayer, Stephan A ^a,b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Anemia; Fever; Hyperglycemia; Medical complications; Outcome; Subarachnoid hemorrhage

Indexed keywords

ERYTHROPOIETIN; IBUPROFEN; INSULIN; PARACETAMOL;

ALLERGIC REACTION; ANEMIA; BLOOD TRANSFUSION; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; BRAIN PERFUSION; BRAIN VENTRICULITIS; CLINICAL TRIAL; COOLING; DEEP VEIN THROMBOSIS; DELIRIUM; DEVICE; DIABETES INSIPIDUS; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPERTENSION; HYPONATREMIA; HYPOTENSION; HYPOXIA; INSULIN INFUSION; KIDNEY FAILURE; LIVER FAILURE; LUNG EDEMA; LUNG EMBOLISM; MENINGITIS; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PNEUMOTHORAX; RESUSCITATION; REVIEW; SEIZURE; STUNNED HEART MUSCLE; SUBARACHNOID HEMORRHAGE; URINARY TRACT INFECTION; WOUND INFECTION;

ANEMIA; ARRHYTHMIA; CRITICAL CARE; ELECTROLYTES; FEVER; HUMANS; HYPERTENSION; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE;

EID: 33645314071     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/01.ccx.0000216571.80944.65     Document Type: Review

References (52)

1. Claassen J, Kreiter KT, Kowalski RG, et al. Effect of acute physiologic dearrangements on outcome after subarachnoid hemorrhage. Crit Care Med 2004; 32:832-838. This study introduces a new Physiologic Derangement Score that can assess severity of metabolic derangements such as hypoxia, metabolic acidosis, hyperglycemia, and cardiovascular instability and examines their contribution to outcome after SAH.
2. Qureshi AI, Suarez JI, Bhardwaj A, et al. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2000; 28:824-829.
3. Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 2003; 34:1852-1858.
4. Rabinstein AA, Friedman JA, Nichols DA, et al. Predictors of outcome after endovascular treatment of cerebral vasospasm. Am J Neuroradiol 2004; 25:1778-1782.
5. Claassen J, Carhuapoma JR, Kreiter KT, et al. Global cerebral edema after subarachnoid hemorrhage: Frequency, predictors and impact on outcome. Stroke 2002; 33:1225-1232.
6. Sarrafzadeh A, Haux D, Kuchler I, et al. Poor-grade aneurysmal subarachnoid hemorrhage: relationship of cerebral metabolism to outcome. J Neurosurg 2004; 100:400-406.
7. Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 2005; 62:410-416.
8. Baldwin ME, Macdonald L, Dezheng H, et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004; 35:2506-2511.
9. Claassen J, Bernardini GL, Kreiter KT, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher Scale revisited. Stroke 2001; 32:2012-2020.
10. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: A report of the multicenter, cooperative aneurysm study. Crit Care Med 1995; 23:1007-1017.
11. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006 (in press).
12. Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage. Relationship to vasospasm and outcome. Neurology 2001; 56:1299-1304.
13. Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologic intensive care unit. Neurology 2003; 60:837-841.
14. Stocchetti N, Protti A, Lattuada M, et al. Impact of pyrexia on neurochemistry and cerebral oxygenation after acute brain injury. J Neurol Neurosurg Psychiatry 2005; 76:1135-1139.
15. Rossi S, Roncati Zanier E, Mauri I, et al. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiatry 2001; 71:448-454.
16. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 1998; 29:529-534.
17. Mayer SA, Kreiter KT, Huddleston D, et al. Fever after subarachnoid hemorrhage: predictors and impact on outcome [abstract]. Crit Care Med 2003; 31 (suppl):A5.
18. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001; 32:1989-1993.
19. Badjatia N, O'Donnell J, Baker JR. Achieving normothermia in febrile subarachnoid hemorrhage patients. Safety and feasibility of a novel intravascular cooling catheter. Neurocrit Care 2005; 1:145-156. This study is a well-written prospective single-center trial investigating safety and feasibility of a systemic cooling device to target normothermia in SAH patients.
20. Mayer SA, Kowalski RG, Prescutti M, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med 2004; 32:2508-2515. Second prospective uncontrolled trial of fever control with systemic surface cooling compared to a regular cooling blanket that shows improved efficacy in achieving normothermia in febrile patients in the neurointensive care unit.
21. Diringer AN. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 2004; 32:559-564.
22. Solomon RA, Post KD, McMurtry JG. Depression of circulating blood volume after subarachnoid hemorrhage: implications for treatment of symptomatic vasospasm. Neurosurgery 1984; 15:354-361.
23. Smith MJ, Le Roux PD, Elliot JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 2004; 101:1-7.
24. Di Georgia MA, Deogaonkar A, Ondrejka J, et al. Blood transfusion following subarachnoid hemorrhage worsens outcome [abstract]. Stroke 2005; 36:506.
25. McMahon TJ, Moon RE, Luschinger BP, et al. Nitric oxide in the human respiratory cycle. Nat Med 2002; 8:711-717.
26. Moore EE. Blood substitutes: the future is now. J Am Coll Surg 2003; 196:1-17.
27. Berezina TL, Zaets SB, Morgan C, et al. Influence of storage on red blood cell rheological properties. J Surg Res 2002; 102:6-12.
28. Forceville X, Plouvier E, Claise C. The deleterious effect of heminic iron in transfused intensive care unit patients. Crit Care Med 2002; 30:1182-1183.
29. Shanwell A, Kristiansson M, Remberger M, Ringden O. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion 1997; 37:678-684.
30. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288:2827-2835.
31. Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98:4044-4049.
32. Leigh R, Zaidat OO, Suri MF, et al. Predictors of hyperacute worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004; 35:1903-1907.
33. Bruno A, Biller J, Adams HP Jr, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of Org 10172 in Acute Stroke Treatment (TOAST) investigators. Neurology 1999; 52:280-284.
34. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intraarterial thrombolysis for ischemic stroke: PROACT II Trial. Neurology 2001; 57:1603-1610.
35. Frontera JA, Fernandez A, Claassen J, et al. Hyperglycemia after subarachnoid hemorrhage: predictors, associated complications, and impact on outcome. Stroke 2006; 37:199-203.
36. Badjatia N, Topcuoglu MA, Buonanno FS, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2005; 33:1603-1609. This study is a retrospective analysis of 352 patients with SAH investigating the effect of admission and mean inpatient hyperglycemia on the occurrence of symptomatic vasospasm and functional outcome at hospital discharge.
37. Juvela S, Siimonen J, Kuhmonen J. Hyperglycemia excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005; 102:998-1003.
38. Allport LE, Butcher KS, Baird TA, et al. Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 2004; 35:1886-1891.
39. Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: Time for active management? Intensive Care Med 2002; 28:1012-1023.
40. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-1353. This study represents a subanalysis of a planned prospective, randomized controlled trial of rigorous insulin therapy in 1548 intensive care patients. The preliminary results of 62 patients with brain injury show the effect of insulin therapy on the duration of mechanical ventilation, intracranial pressure, use of vasopressures, frequency of seizures, and diabetes insipidus.
41. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
42. Bell DA, Strong AJ. Glucose/insulin infusions in the treatment of subarachnoid hemorrhage: a feasibility study. Br J Neurosurg 2005; 19:21-24.
43. Yasser LS, Lim N, Amaral ACKB, et al. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Card 2004; 96:369-373.
44. Van den Berghe WM, Algra A, Rinkel GJE. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke 2004; 35:644-648.
45. Mayer SA, Fink ME, Homma S, et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology 1994; 44:815-820.
46. Tung P, Kopelnik A, Banki N, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004; 35:548-553. This study shows that troponin elevation after SAH is associated with poor clinical grade, female gender, hypotension, and increased vasopressor requirements.
47. Naidech AM, Kreiter KT, Janjua N. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005; 112:2851-2856. The authors investigated the impact of peak troponin I on cardiopulmonary complications, delayed cerebral ischemia and outcome after SAH in a thorough retrospective analysis.
48. Friedman JA, Pichelman MA, Piepgras DG, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52:1025-1032.
49. Kim DH, Haney CL, Van Ginhoven G. Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol. Neurocrit Care 2005; 3:11-15.
50. McGirt MJ, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004; 54:1369-1374.
51. Qureshi AI, Suri MFK, Sung GY, et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2002; 50:749-756.
52. Hirashima Y, Hamada H, Kurimoto M, et al. Decrease in platelet count as an independent factor for symptomatic vasospasm following aneurismal subarachnoid hemorrhage. J Neurosurg 2005; 102:882-887.